Highly Potent

Sep 01, 2012
Pharmaceutical Technology
Pfizer has two manufacturing facilities in Germany for high-potency manufacturing, respectively in Freiburg and Illertissen. Pharmaceutical Technology's Executive Editor Patricia Van Arnum visited the facilities and spoke to the company about the design and operation of these facilities.
Jul 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Companies roll out expansions in manufacturing high-potency APIs and finished products.
Apr 18, 2012
Equipment and Processing Report
The growing use of high-potency APIs is leading to changes in how the pharmaceutical industry looks at containment.
Sep 02, 2011
By Pharmaceutical Technology Editors
Powder Systems Ltd's (PSL's) new GFD™ isolator combines the latest innovation to provide a high containment lab scale filtration and drying solution with the same reliability and benefits as PSL high containment production size filter dryers.
Sep 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Highly potent APIs (HPAPIs) represent a growing area of interest for the pharma industry. Mark Griffiths, CEO of Carbogen Amcis AG, explains why.
Sep 01, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A Q&A with Joe Cascone, director of potent pharmaceutical development at Metrics, moderated by Patricia Van Arnum. Discussion of the key considerations made in facility design, equipment selection, and operations to achieve desired levels of containment.
Jul 01, 2011
By Pharmaceutical Technology Editors
A technical leader in solid dosage forms Pfizer CentreSource provides analytical, technical, regulatory, developmental, manufacturing and packaging support that spans the specialized realm of highly potent solid oral dose drug products.
Jun 03, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
Jun 02, 2011
Pharmaceutical Technology
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
Apr 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
The main challenge for tablet manufacturers processing highly potent APIs (HPAPIs) is to protect equipment operators from the inhalation of airborne particles and prevent skin contact with the product during the entire production process: dispensing, granulation, tablet compression, coating and packaging.
native1_300x100
lorem ipsum